329 related articles for article (PubMed ID: 18791450)
1. Novel antibodies to the donor stem cell population CD34+/VEGFR-2+ are associated with rejection after hematopoietic stem cell transplantation.
Nordlander A; Mattsson J; Sundberg B; Sumitran-Holgersson S
Transplantation; 2008 Sep; 86(5):686-96. PubMed ID: 18791450
[TBL] [Abstract][Full Text] [Related]
2. Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantation.
Nordlander A; Uhlin M; Ringdén O; Kumlien G; Hauzenberger D; Mattsson J
Transpl Immunol; 2011 Sep; 25(2-3):153-8. PubMed ID: 21712089
[TBL] [Abstract][Full Text] [Related]
3. A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors.
Eyrich M; Leiler C; Lang P; Schilbach K; Schumm M; Bader P; Greil J; Klingebiel T; Handgretinger R; Niethammer D; Schlegel PG
Bone Marrow Transplant; 2003 Aug; 32(4):379-90. PubMed ID: 12900774
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of hemoangiogenic progenitors during cynomolgus monkey embryonic stem cell differentiation.
Umeda K; Heike T; Yoshimoto M; Shinoda G; Shiota M; Suemori H; Luo HY; Chui DH; Torii R; Shibuya M; Nakatsuji N; Nakahata T
Stem Cells; 2006 May; 24(5):1348-58. PubMed ID: 16410394
[TBL] [Abstract][Full Text] [Related]
5. CD34+ cell dose, conditioning regimen and prior chemotherapy: factors with significant impact on the early kinetics of donor chimerism after allogeneic hematopoietic cell transplantation.
Mohr B; Koch R; Thiede C; Kroschinsky F; Ehninger G; Bornhäuser M
Bone Marrow Transplant; 2004 Dec; 34(11):949-54. PubMed ID: 15489870
[TBL] [Abstract][Full Text] [Related]
6. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status.
Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Yu-Wang ; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
Biol Blood Marrow Transplant; 2009 May; 15(5):632-8. PubMed ID: 19361756
[TBL] [Abstract][Full Text] [Related]
7. The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation.
Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Wang Y; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
Pediatr Blood Cancer; 2009 Dec; 53(6):1100-6. PubMed ID: 19743519
[TBL] [Abstract][Full Text] [Related]
8. Selection of stem cells by using antibodies that target different CD34 epitopes yields different patterns of T-cell differentiation.
Otto M; Chen X; Martin WJ; Leung W; Knowles J; Holladay M; Houston J; Handgretinger R; Barfield RC
Stem Cells; 2007 Feb; 25(2):537-42. PubMed ID: 17023516
[TBL] [Abstract][Full Text] [Related]
9. Absence of a CD34- hematopoietic precursor population in recipients of CD34+ stem cell transplantation.
Kato S; Ando K; Nakamura Y; Muguruma Y; Sato T; Yabe H; Yabe M; Hattori K; Yasuda Y; Hotta T
Bone Marrow Transplant; 2001 Sep; 28(6):587-95. PubMed ID: 11607772
[TBL] [Abstract][Full Text] [Related]
10. Infusion of donor-derived hematopoietic stem cells in organ transplantation: clinical data.
De Pauw L; Toungouz M; Goldman M
Transplantation; 2003 May; 75(9 Suppl):46S-49S. PubMed ID: 12819491
[TBL] [Abstract][Full Text] [Related]
11. Increased graft content of vascular progenitor cells is associated with reduced toxicity following autologous hematopoietic transplantation.
Iqbal T; Rajagopal T; Halpenny M; Yang L; Martin L; Giulivi A; McDiarmid S; Huebsch L; Allan DS
Exp Hematol; 2008 Apr; 36(4):506-12. PubMed ID: 18261841
[TBL] [Abstract][Full Text] [Related]
12. Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation.
Perseghin P; Balduzzi A; Galimberti S; Dassi M; Baldini V; Valsecchi MG; Pioltelli P; Bonanomi S; Faccini P; Rovelli A; Pogliani EM; Uderzo C
Bone Marrow Transplant; 2003 Jul; 32(2):231-6. PubMed ID: 12838290
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial DNA sequence heterogeneity of single CD34+ cells after nonmyeloablative allogeneic stem cell transplantation.
Yao YG; Childs RW; Kajigaya S; McCoy JP; Young NS
Stem Cells; 2007 Oct; 25(10):2670-6. PubMed ID: 17628021
[TBL] [Abstract][Full Text] [Related]
14. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation.
Wolff SN
Bone Marrow Transplant; 2002 Apr; 29(7):545-52. PubMed ID: 11979301
[TBL] [Abstract][Full Text] [Related]
15. The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms.
Palomo M; Diaz-Ricart M; Carbo C; Rovira M; Fernandez-Aviles F; Escolar G; Eissner G; Holler E; Carreras E
Biol Blood Marrow Transplant; 2009 May; 15(5):537-46. PubMed ID: 19361745
[TBL] [Abstract][Full Text] [Related]
16. Living-donor lobar lung transplantation for pulmonary complications after hematopoietic stem cell transplantation.
Yamane M; Sano Y; Toyooka S; Okazaki M; Date H; Oto T
Transplantation; 2008 Dec; 86(12):1767-70. PubMed ID: 19104419
[TBL] [Abstract][Full Text] [Related]
17. Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma.
Yoon DH; Sohn BS; Jang G; Kim EK; Kang BW; Kim C; Kim JE; Kim S; Lee DH; Lee JS; Park SJ; Park CJ; Huh J; Suh C
Transfusion; 2009 Sep; 49(9):1890-900. PubMed ID: 19453991
[TBL] [Abstract][Full Text] [Related]
18. Number of megakaryocytic progenitors and adhesion molecule expression of stem cells predict platelet engraftment after allogeneic hematopoietic stem cell transplantation.
Woo KS; Goh RY; Kim SH; Kwon HC; Kim HJ; Lee YH; Han JY
Cytotherapy; 2007; 9(6):555-61. PubMed ID: 17882720
[TBL] [Abstract][Full Text] [Related]
19. In pursuit of the ultimate: the initial Ahmedabad journey toward transplantation tolerance.
Trivedi HL; Vanikar AV; Modi PR; Shah PR; Shah VR; Trivedi VB
Transplant Proc; 2007 Apr; 39(3):653-7. PubMed ID: 17445566
[TBL] [Abstract][Full Text] [Related]
20. [Effect of growth factor on the phenotype of subpopulations and on the kinetics of CD34+ cells in the peripheral blood and in grafts of peripheral stem cells in patients with non-Hodgkin's lymphoma indicated for autologous peripheral blood stem cell transplantation].
Klabusay M; Lysák D; Hrabcáková V; Navrátil M; Coupek P; Mayer J
Cas Lek Cesk; 2008; 147(6):319-24. PubMed ID: 18724529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
